Wednesday, July 8, 2026

biotech · Attention Deficit Hyperactivity Disorder · Vascular Ehlers-Danlos Syndrome · AYTU

AYTU BIOPHARMA

News and analysis for AYTU BIOPHARMA on NovaPharmaNews — regulatory, clinical, and market coverage.

Denver, USA HQ
2015 Founded
105 Employees
Public company Type
AYTU · NYSE Ticker
Company details
Status
Public
HQ
Denver, USA
Founded
2015
Employees
105
Programs
3
Drugs
5
Patents
4
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning AYTU BIOPHARMA — regulatory, clinical, and market coverage.

News and analysis for AYTU BIOPHARMA on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning AYTU BIOPHARMA yet.

Back to company overview →